Fluticasone Propionate 250 mcg + Salmeterol 25 mcg is a combination inhalation therapy used for the long-term management of asthma and chronic obstructive pulmonary disease (COPD). This dual-action formulation combines an inhaled corticosteroid (ICS) and a long-acting beta2-agonist (LABA) to provide both anti-inflammatory and bronchodilatory effects. Fluticasone Propionate is a corticosteroid that works by reducing airway inflammation, swelling, and mucus production. It helps prevent asthma attacks and improves overall lung function. Salmeterol is a long-acting bronchodilator that relaxes the airway muscles, allowing easier breathing for up to 12 hours. It helps prevent bronchospasm and controls symptoms like wheezing, breathlessness, and chest tightness. This combination therapy is commonly prescribed for maintenance treatment and is not intended for immediate relief of acute asthma attacks.
